Skip to main content
NCBI home page
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1995 Feb;39(2):325–328. doi: 10.1128/aac.39.2.325

Effects of atovaquone and other inhibitors on Pneumocystis carinii dihydroorotate dehydrogenase.

I Ittarat 1, W Asawamahasakda 1, M S Bartlett 1, J W Smith 1, S R Meshnick 1
PMCID: PMC162535  PMID: 7726490

Abstract

Dihydroorotate dehydrogenase (DHOD) is a pyrimidine biosynthetic enzyme which is usually directly linked to the mitochondrial respiratory chain. Antimalarial naphthoquinones such as atovaquone (566c80) inhibit malarial DHOD by inhibiting electron transport. Since atovaquone also has therapeutic activity against Pneumocystis carinii, the P. carinii DHOD may also be an important drug target. Organisms were obtained from immunosuppressed rats, incubated for 24 h in a short-term in vitro culture system, and then lysed. P. carinii lysates catalyzed the generation of orotate from dihydroorotate at a rate of 852 pmol/mg of protein per min. Control preparations made from uninfected mice showed much less total enzymatic activity and enzyme specific activity. As expected, P. carinii DHOD activity was susceptible to respiratory inhibitors such as cyanide, antimycin A, and salicylhydroxamic acid (SHAM). Susceptibility to SHAM suggests the presence of an alternative oxidase. In contrast, neither pentamidine nor 5-hydroxy-6-demethylprimaquine (5H6DP), a quinone metabolite of primaquine, inhibited the enzyme. Atovaquone inhibited DHOD by 76.3% at 100 microM and 36.5% at 10 microM. A similar degree of inhibition was found when the organisms were preincubated with the drug. Atovaquone inhibited P. carinii growth in vitro at a somewhat lower concentration (between 0.3 and 3 microM). In contrast, Plasmodium falciparum growth and enzyme activity are susceptible to nanomolar concentrations of atovaquone. Thus, while it is possible that atovaquone acts by inhibiting the P. carinii electron transport chain, the possibility of another drug target cannot be excluded.

Full Text

The Full Text of this article is available as a PDF (200.8 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aikawa M., Beaudoin R. L. Plasmodium fallax: high-resolution autoradiography of exoerythrocytic stages treated with Primaquine in vitro. Exp Parasitol. 1970 Jun;27(3):454–463. doi: 10.1016/0014-4894(70)90050-0. [DOI] [PubMed] [Google Scholar]
  2. Artymowicz R. J., James V. E. Atovaquone: a new antipneumocystis agent. Clin Pharm. 1993 Aug;12(8):563–570. [PubMed] [Google Scholar]
  3. Bartlett M. S., Eichholtz R., Smith J. W. Antimicrobial susceptibility of Pneumocystis carinii in culture. Diagn Microbiol Infect Dis. 1985 Sep;3(5):381–387. doi: 10.1016/0732-8893(85)90076-8. [DOI] [PubMed] [Google Scholar]
  4. Bates M. D., Meshnick S. R., Sigler C. I., Leland P., Hollingdale M. R. In vitro effects of primaquine and primaquine metabolites on exoerythrocytic stages of Plasmodium berghei. Am J Trop Med Hyg. 1990 Jun;42(6):532–537. doi: 10.4269/ajtmh.1990.42.532. [DOI] [PubMed] [Google Scholar]
  5. Chen J. J., Jones M. E. The cellular location of dihydroorotate dehydrogenase: relation to de novo biosynthesis of pyrimidines. Arch Biochem Biophys. 1976 Sep;176(1):82–90. doi: 10.1016/0003-9861(76)90143-0. [DOI] [PubMed] [Google Scholar]
  6. Chen S. F., Papp L. M., Ardecky R. J., Rao G. V., Hesson D. P., Forbes M., Dexter D. L. Structure-activity relationship of quinoline carboxylic acids. A new class of inhibitors of dihydroorotate dehydrogenase. Biochem Pharmacol. 1990 Aug 15;40(4):709–714. doi: 10.1016/0006-2952(90)90305-5. [DOI] [PubMed] [Google Scholar]
  7. Davies C. S., Pudney M., Nicholas J. C., Sinden R. E. The novel hydroxynaphthoquinone 566C80 inhibits the development of liver stages of Plasmodium berghei cultured in vitro. Parasitology. 1993 Jan;106(Pt 1):1–6. doi: 10.1017/s0031182000074746. [DOI] [PubMed] [Google Scholar]
  8. Durkin M. M., Bartlett M. S., Queener S. F., Shaw M. M., Smith J. W. A culture method allowing production of relatively pure Pneumocystis carinii trophozoites. J Protozool. 1989 Jan-Feb;36(1):31S–32S. doi: 10.1111/j.1550-7408.1989.tb02681.x. [DOI] [PubMed] [Google Scholar]
  9. Dykstra C. C., Tidwell R. R. Inhibition of topoisomerases from Pneumocystis carinii by aromatic dicationic molecules. J Protozool. 1991 Nov-Dec;38(6):78S–81S. [PubMed] [Google Scholar]
  10. Forman H. J., Kennedy J. Mammalian dihydroorotate dehydrogenase: physical and catalytic properties of the primary enzyme. Arch Biochem Biophys. 1978 Nov;191(1):23–31. doi: 10.1016/0003-9861(78)90063-2. [DOI] [PubMed] [Google Scholar]
  11. Fry M., Pudney M. Site of action of the antimalarial hydroxynaphthoquinone, 2-[trans-4-(4'-chlorophenyl) cyclohexyl]-3-hydroxy-1,4-naphthoquinone (566C80). Biochem Pharmacol. 1992 Apr 1;43(7):1545–1553. doi: 10.1016/0006-2952(92)90213-3. [DOI] [PubMed] [Google Scholar]
  12. Goheen M. P., Bartlett M. S., Shaw M. M., Queener S. F., Smith J. W. Effects of 8-aminoquinolines on the ultrastructural morphology of Pneumocystis carinii. Int J Exp Pathol. 1993 Aug;74(4):379–387. [PMC free article] [PubMed] [Google Scholar]
  13. Gutteridge W. E. 566C80, an antimalarial hydroxynaphthoquinone with broad spectrum: experimental activity against opportunistic parasitic infections of AIDS patients. J Protozool. 1991 Nov-Dec;38(6):141S–143S. [PubMed] [Google Scholar]
  14. Howells R. E., Pters W., Fullard J. The chemotherapy of rodent malaria. 13. Fine structural changes observed in the eryhrocytic stages of Plasmodium berghei berghei following exposureto primaquine and menoctone. Ann Trop Med Parasitol. 1970 Jun;64(2):203–207. [PubMed] [Google Scholar]
  15. Hudson A. T., Randall A. W., Fry M., Ginger C. D., Hill B., Latter V. S., McHardy N., Williams R. B. Novel anti-malarial hydroxynaphthoquinones with potent broad spectrum anti-protozoal activity. Parasitology. 1985 Feb;90(Pt 1):45–55. doi: 10.1017/s0031182000049003. [DOI] [PubMed] [Google Scholar]
  16. Ittarat I., Asawamahasakda W., Meshnick S. R. The effects of antimalarials on the Plasmodium falciparum dihydroorotate dehydrogenase. Exp Parasitol. 1994 Aug;79(1):50–56. doi: 10.1006/expr.1994.1058. [DOI] [PubMed] [Google Scholar]
  17. Ittarat I., Webster H. K., Yuthavong Y. High-performance liquid chromatographic determination of dihydroorotate dehydrogenase of Plasmodium falciparum and effects of antimalarials on enzyme activity. J Chromatogr. 1992 Nov 6;582(1-2):57–64. doi: 10.1016/0378-4347(92)80302-7. [DOI] [PubMed] [Google Scholar]
  18. Krungkrai J., Krungkrai S. R., Phakanont K. Antimalarial activity of orotate analogs that inhibit dihydroorotase and dihydroorotate dehydrogenase. Biochem Pharmacol. 1992 Mar 17;43(6):1295–1301. doi: 10.1016/0006-2952(92)90506-e. [DOI] [PubMed] [Google Scholar]
  19. Miller R. W. Dihydroorotate dehydrogenase (Neurospora). Methods Enzymol. 1978;51:63–69. doi: 10.1016/s0076-6879(78)51011-2. [DOI] [PubMed] [Google Scholar]
  20. Pascal R. A., Jr, Walsh C. T. Mechanistic studies with deuterated dihydroorotates on the dihydroorotate oxidase from Crithidia fasciculata. Biochemistry. 1984 Jun 5;23(12):2745–2752. doi: 10.1021/bi00307a033. [DOI] [PubMed] [Google Scholar]
  21. Queener S. F., Bartlett M. S., Nasr M., Smith J. W. 8-aminoquinolines effective against Pneumocystis carinii in vitro and in vivo. Antimicrob Agents Chemother. 1993 Oct;37(10):2166–2172. doi: 10.1128/aac.37.10.2166. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Rathod P. K., Khatri A., Hubbert T., Milhous W. K. Selective activity of 5-fluoroorotic acid against Plasmodium falciparum in vitro. Antimicrob Agents Chemother. 1989 Jul;33(7):1090–1094. doi: 10.1128/aac.33.7.1090. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Tidwell R. R., Jones S. K., Geratz J. D., Ohemeng K. A., Cory M., Hall J. E. Analogues of 1,5-bis(4-amidinophenoxy)pentane (pentamidine) in the treatment of experimental Pneumocystis carinii pneumonia. J Med Chem. 1990 Apr;33(4):1252–1257. doi: 10.1021/jm00166a026. [DOI] [PubMed] [Google Scholar]
  24. Warhurst D. C. Why are primaquine and other 8-aminoquinolines particularly effective against the mature gametocytes and the hypnozoites of malaria? Ann Trop Med Parasitol. 1984 Apr;78(2):165–165. doi: 10.1080/00034983.1984.11811790. [DOI] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES